Could you please elaborate on the distinction between PDUFA and GDUFA? As both relate to the pharmaceutical industry, I'm curious to understand how they differ in terms of their purpose, scope, and potential impact on drug development and approval processes. Specifically, what are the key differences in their objectives, the agencies they involve, and the types of drugs they primarily focus on?